辉瑞-JPM-20240108.pdf

1、42ndAnnual J.P.Morgan Healthcare ConferenceBreakthroughs that change patients lives January 8,202442ndAnnual J.P.Morgan Healthcare Conference42ndAnnual J.P.Morgan Healthcare Conference Our discussions during this conference call will include forward-looking statements that are subject to substantial

2、 risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements.We may include forward-looking statements about,among other topics,our anticipated operating and financial performance,including financial guidance and projections;changes

3、 to Pfizers commercial organization;reorganizations;business plans,strategy and prospects;expectations for our product pipeline,in-line products and product candidates,including anticipated regulatory submissions,data read-outs,study starts,approvals,launches,clinical trial results and other develop

4、ing data,revenue contribution and projections,potential pricing and reimbursement,potential market dynamics,size and utilization rates,growth,performance,timing of exclusivity and potential benefits;strategic reviews,capital allocation objectives,an enterprise-wide cost realignment program(including

5、 anticipated costs,savings and potential benefits),dividends and share repurchases;plans for and prospects of our acquisitions,dispositions and other business development activities,including our recentacquisition of Seagen,and our ability to successfully capitalize on these opportunities;manufactur

6、ing and product supply;our ongoing efforts to respond to COVID-19,including our COVID-19 products;and our expectations regarding the impact of COVID-19 on our business,operations and financial results.Among other things,statements regarding revenue and earnings per share growth;anticipated operating